Keloid

(redirected from Keloid scar)
Also found in: Dictionary, Thesaurus, Medical.
Related to Keloid scar: Hypertrophic scar

keloid

[′kē‚lȯid]
(medicine)
A firm, elevated fibrous formation of tissue at the site of a scar.

Keloid

 

a tumor-like growth of the fibrous connective tissue of the skin.

The causes of keloid development are not clear. Certain persons have a predisposition to their development. A distinction is made between true (spontaneous) keloids, which develop on visibly unchanged skin, and false keloids, which develop at the site of a scar after trauma (mechanical, thermal, chemical) or purulent disease (a furuncle, for example). A true keloid is a slightly elevated formation (5–8 mm above the skin surface) of whitish or pinkish color and dense consistency, with a smooth, shiny surface. Keloids appear most often in young people in the area of the chest, neck, and pinnae; and more rarely, on the face and limbs. Growth takes place for several weeks or sometimes months, after which the dimensions of the keloid remain unchanged throughout the patient’s lifetime. Treatment consists of injections of hyaluronidase and vitreous body; administration of vitamins PP, B2, and C; electrophoresis of potassium iodide; paraffin therapy; and X-ray therapy.

References in periodicals archive ?
Many theories exist to explain this haphazard collagen deposition in keloid scars.
CLINICEL, an over-the-counter product line for the prevention and management of hypertrophic and keloid scars, was launched during the second quarter of 1998 with an aggressive consumer media campaign supported by distribution through retail pharmacies.
NYSE:ACS) for CLINICEL(TM), the company's FDA-cleared topical therapy for the management and prevention of hypertrophic and keloid scars.
He will lead the Company's efforts in the areas of Training, Education, and Clinical research as the Company continues to expand its SRT technology for non-invasive skin cancer treatment for NMSC as well as treatment for Keloid scars.
based Eckerd Drug Stores has signed an initial purchase order for CLINICEL(TM), Life Medical Sciences' FDA-cleared topical therapy for treating hypertrophic and keloid scars.
Cockerell will lead the distinguished members of the Medical Advisory Board as the Company continues to provide technology for non-invasive skin cancer treatment for NMSC as well as treatment for keloid scars.
Patent Office on a broad patent covering CLINICEL(TM) silicon gel-filled cushions, the company's FDA-cleared topical therapy for treating hypertrophic and keloid scars.
Painful and potentially disfiguring keloid scars are very difficult to effectively treat by surgery or other means due to recurrence rates as high as 45 to 100%.
placed an initial stocking order as the latest major distributor of the CLINICEL(TM) line of silicone gel-filled cushions, the company's FDA-cleared topical therapy for treating hypertrophic and keloid scars.
Keloid scars predominantly affect patients of African descent but are also seen in patients of Indian and Asian descent, but less commonly in Caucasians.
These products are designed to provide comfortable, topical therapy for treating hypertrophic and keloid scars.
These products are used by clinicians to treat hypertrophic and keloid scars.